Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
AlzChem Group AG: A reportable insider transaction was published on 15th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th November 2024,
The Insider Transaction was made by Weichselbaumer, Dr. Georg . The transaction toke place on 13th November 2024. . The aggregated volume was 152.760,00 EUR, based on an average price of 50,92 EUR. The nature of the Investment was Buy.
AlzChem Group AG: A reportable insider transaction was published on 14th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 14th November 2024,
The Insider Transaction was made by Englmaier, Klaus Dieter . The transaction toke place on 13th November 2024. . The aggregated volume was 76.380,00 EUR, based on an average price of 50,92 EUR. The nature of the Investment was Buy.
AlzChem Group AG: A reportable insider transaction was published on 14th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 14th November 2024,
The Insider Transaction was made by Niedermaier, Herr Andreas . The transaction toke place on 13th November 2024. . The aggregated volume was 101.840,00 EUR, based on an average price of 50,92 EUR. The nature of the Investment was Buy.
AlzChem Group AG: A reportable insider transaction was published on 14th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 14th November 2024,
The Insider Transaction was made by Lösler, Andreas . The transaction toke place on 13th November 2024. . The aggregated volume was 81.472,00 EUR, based on an average price of 50,92 EUR. The nature of the Investment was Buy.
AlzChem Group AG: A reportable insider transaction was published on 12th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 12th November 2024,
The Insider Transaction was made by Englmaier, Klaus Dieter . The transaction toke place on 12th November 2024. The order was executed at the trading place Tradegate. . The aggregated volume was 35.227,00 EUR, based on an average price of 53,46 EUR. The nature of the Investment was Buy.
AlzChem Group AG: A reportable insider transaction was published on 12th November 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 12th November 2024,
The Insider Transaction was made by Englmaier, Klaus Dieter . The transaction toke place on 11th November 2024. The order was executed at the trading place Tradegate. . The aggregated volume was 45.209,40 EUR, based on an average price of 53,76 EUR. The nature of the Investment was Buy.
Type | Total | Last | Made by | Go to |
---|---|---|---|---|
Equity Story | 79 | 12th November 2024 | EQS Group AG | EQS |
Corporate Research | 0 | - | - | Corporate Research |
Short Seller (DE) | 0 | - | - | SSR (DE) |
Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.